We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TLKM:IDXPT Telkom Indonesia (Persero) Tbk Class B Analysis

Data as of 2026-09-02 - not real-time

IDR 2,590.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk is priced at IDR 2,590.00, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 4.4%. RSI sits at 46.7, which reads as neutral, and MACD momentum is bearish. Watch IDR 2,550.00 as support and IDR 2,790.00 as the nearer resistance level.
The shares look undervalued, trading on 14.5 times earnings in line with a sector average of 16.1. Sell-side targets cluster 35.4% above the current quote. Revenue is growing at 6.4% on a 12.0% profit margin. The 8.55% dividend yield looks stretched against payout coverage.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 28.1%, a beta of 0.08 and a maximum drawdown of 40.4%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.

Top Market Events

Dalam transaksi tahap 2 ini, Telkom akan mengalihkan segmen usaha Wholesale Fiber Connectivity kepada TIF melalui...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 3106.90
  • MACD momentum is negative
  • Maximum drawdown of 40.4%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 14.5 versus sector average of 16.1
  • Dividend yield of 8.55% looks stretched against payout coverage
  • Trading below the 200-day average of 3106.90

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 14.5 versus sector average of 16.1
  • Dividend yield of 8.55% looks stretched against payout coverage
  • Analyst targets imply +35.4% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth6.40%
Profit Margin12.01%
P/E Ratio14.5
ROE17.68%
ROA7.58%
Debt/Equity59.98
P/B Ratio1.9
Op. Cash FlowIDR66131.0B
Free Cash FlowIDR57332.4B
Industry P/E16.1

Technical Analysis

TrendNeutral
RSI46.7
SupportIDR 2,550.00
ResistanceIDR 2,790.00
MA 20IDR 2,625.50
MA 50IDR 2,582.60
MA 200IDR 3,106.90
MACDBearish
VolumeStable
Fear & Greed Index92.25

Valuation

Fair ValueIDR 9,446.38
Target PriceIDR 3,505.91
Upside/Downside35.36%
GradeUndervalued
TypeValue
Dividend Yield8.55%

Risk Assessment

Beta0.08
Volatility28.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.